Tsukuba, Japan

Minako Hashizume

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Minako Hashizume – Innovator in Pharmacological Compounds

Introduction

Minako Hashizume, a talented inventor based in Tsukuba, Japan, has made significant contributions in the field of pharmacology. With two patents to her name, she has focused her research on innovative compounds that exhibit pharmacological efficacy.

Latest Patents

Among her latest innovations is a pyrazolothiazole compound, which is represented by a detailed formula exhibiting excellent CRF receptor antagonism. This compound, or its pharmacologically acceptable salt, has demonstrated promising pharmacological activity, safety, and pharmacokinetic properties, making it a potential candidate for therapeutic applications. The intricate chemical properties include various substituents, such as alkyl, alkoxy, cycloalkyl groups, and several functional groups designed to enhance its efficacy as a drug.

Career Highlights

Minako Hashizume has dedicated her career to research and development at Eisai R&D Management Co., Ltd. Her work reflects a continuous pursuit of advances in medicinal chemistry and pharmacology, showcasing her commitment to developing effective therapeutic agents.

Collaborations

Throughout her career, Minako has collaborated with esteemed colleagues Kogyoku Shin and Taro Terauchi, further enriching her research endeavors. These collaborations have contributed to a productive exchange of ideas, resulting in innovative solutions and advancements in their field.

Conclusion

Minako Hashizume stands out as a prominent inventor, contributing valuable innovations to pharmacology. Her ongoing efforts and collaborative spirit highlight the importance of teamwork in scientific discovery, paving the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…